The post The GENIUS Act Is Already Law. Banks Shouldn’t Try to Rewrite It Now appeared on BitcoinEthereumNews.com. Healthy competition drives innovation and better products for consumers; it is at the center of American economic leadership. Unfortunately, now that the bipartisan GENIUS Act has been signed into law, major legacy financial institutions seem to be having second thoughts about the innovations that stablecoins can bring to financial markets. Bank lobbying groups and public affairs teams have been peppering Congress with complaints about the law, urging members to reopen debate and introduce changes to the legislation that will ensure the stablecoin market doesn’t grow too quickly, protecting banks’ profits and stifling consumer choice. This reactionary response is both overblown and unnecessary. What legacy financial firms should do instead is embrace competition and offer exciting new products and services that consumers want, not try to kneecap emerging players through anti-innovation rules and regulations. The GENIUS Act was carefully designed with a thorough bipartisan process to strengthen consumer safeguards, ensure regulatory oversight, and preserve financial stability. Efforts to roll back its provisions are less about protecting families and more about protecting entrenched banking interests from the competition that helps ensure the U.S. banking system stays the strongest and most innovative in the world. Critics warn that allowing stablecoins to provide rewards could lead to massive deposit outflows from community banks, with figures as high as $6.6 trillion cited. But closer examination shows this fear is unfounded. A July 2025 analysis by consulting firm Charles River Associates found no statistically significant relationship between stablecoin adoption and community bank deposit outflows. In fact, the overwhelming majority of stablecoin reserves remain in the traditional financial system — either in commercial bank accounts or in short-term Treasuries — where they continue to support liquidity and credit in the broader U.S. economy. The dire estimates rely on unrealistic assumptions that every dollar of stablecoin issuance permanently… The post The GENIUS Act Is Already Law. Banks Shouldn’t Try to Rewrite It Now appeared on BitcoinEthereumNews.com. Healthy competition drives innovation and better products for consumers; it is at the center of American economic leadership. Unfortunately, now that the bipartisan GENIUS Act has been signed into law, major legacy financial institutions seem to be having second thoughts about the innovations that stablecoins can bring to financial markets. Bank lobbying groups and public affairs teams have been peppering Congress with complaints about the law, urging members to reopen debate and introduce changes to the legislation that will ensure the stablecoin market doesn’t grow too quickly, protecting banks’ profits and stifling consumer choice. This reactionary response is both overblown and unnecessary. What legacy financial firms should do instead is embrace competition and offer exciting new products and services that consumers want, not try to kneecap emerging players through anti-innovation rules and regulations. The GENIUS Act was carefully designed with a thorough bipartisan process to strengthen consumer safeguards, ensure regulatory oversight, and preserve financial stability. Efforts to roll back its provisions are less about protecting families and more about protecting entrenched banking interests from the competition that helps ensure the U.S. banking system stays the strongest and most innovative in the world. Critics warn that allowing stablecoins to provide rewards could lead to massive deposit outflows from community banks, with figures as high as $6.6 trillion cited. But closer examination shows this fear is unfounded. A July 2025 analysis by consulting firm Charles River Associates found no statistically significant relationship between stablecoin adoption and community bank deposit outflows. In fact, the overwhelming majority of stablecoin reserves remain in the traditional financial system — either in commercial bank accounts or in short-term Treasuries — where they continue to support liquidity and credit in the broader U.S. economy. The dire estimates rely on unrealistic assumptions that every dollar of stablecoin issuance permanently…

The GENIUS Act Is Already Law. Banks Shouldn’t Try to Rewrite It Now

2025/09/18 09:39

Healthy competition drives innovation and better products for consumers; it is at the center of American economic leadership. Unfortunately, now that the bipartisan GENIUS Act has been signed into law, major legacy financial institutions seem to be having second thoughts about the innovations that stablecoins can bring to financial markets. Bank lobbying groups and public affairs teams have been peppering Congress with complaints about the law, urging members to reopen debate and introduce changes to the legislation that will ensure the stablecoin market doesn’t grow too quickly, protecting banks’ profits and stifling consumer choice.

This reactionary response is both overblown and unnecessary. What legacy financial firms should do instead is embrace competition and offer exciting new products and services that consumers want, not try to kneecap emerging players through anti-innovation rules and regulations.

The GENIUS Act was carefully designed with a thorough bipartisan process to strengthen consumer safeguards, ensure regulatory oversight, and preserve financial stability. Efforts to roll back its provisions are less about protecting families and more about protecting entrenched banking interests from the competition that helps ensure the U.S. banking system stays the strongest and most innovative in the world.

Critics warn that allowing stablecoins to provide rewards could lead to massive deposit outflows from community banks, with figures as high as $6.6 trillion cited. But closer examination shows this fear is unfounded. A July 2025 analysis by consulting firm Charles River Associates found no statistically significant relationship between stablecoin adoption and community bank deposit outflows. In fact, the overwhelming majority of stablecoin reserves remain in the traditional financial system — either in commercial bank accounts or in short-term Treasuries — where they continue to support liquidity and credit in the broader U.S. economy. The dire estimates rely on unrealistic assumptions that every dollar of stablecoin issuance permanently leaves the banking system.

Stablecoins are not siphoning resources away from lending. If anything, their growth may increase inflows to the U.S. money supply over time, according to a Treasury Department report. That means Americans can benefit from modern, programmable digital dollars without threatening the availability of credit in their communities.

Others have urged the repeal of Section 16(d) of the GENIUS Act, which allows subsidiaries of state-chartered institutions to effect stablecoin business across state lines without needing additional licenses. If this important part of GENIUS is repealed, the result would be a fragmented, Balkanized and ineffective regulatory regime that stifles interstate commerce.

Innovation has always been the lifeblood of American capitalism — it’s what separates dynamic market economies from stagnant, protected ones. Rather than trying to box out new market entrants, banks should be working to ensure their current and future customers have access to cutting-edge products and services, including healthier interest rates on deposit accounts.

While the Federal Reserve’s target rate today is above 4%, the average checking account yields just 0.07% and savings accounts 0.39%. That gap doesn’t reflect consumer protection; it reflects value captured by banks. Stablecoin rewards programs, by contrast, allow platforms to compete head-to-head for customers in ways that force incumbents to offer better value. Consumers win when competition exists.

The GENIUS Act positions the U.S. as the global leader in digital finance while maintaining the strongest consumer protections. Congress already debated and settled these issues through careful bipartisan deliberation. The law requires one-to-one reserves in cash or Treasuries, robust licensing and supervision, and transparency far beyond what is expected of traditional deposits. Relitigating these questions now would undermine that consensus and threaten to slow America’s leadership in digital finance.

Stablecoins do not represent a loophole, they represent an innovation that preserves the stability of the banking system while giving consumers the benefit of competition. Policymakers should see through this fear campaign and stand by the balanced, bipartisan framework Congress already enacted.

Innovation and competition built American financial leadership. It’s time to let it work again — and not allow incumbent interests to stifle its promising growth. American consumers deserve nothing less.

Source: https://www.coindesk.com/opinion/2025/09/16/the-genius-act-is-already-law-banks-shouldn-t-try-to-rewrite-it-now

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like

RFK Jr. Is Targeting Vaccines And Tylenol. Are Prozac And Ozempic Next?

RFK Jr. Is Targeting Vaccines And Tylenol. Are Prozac And Ozempic Next?

The post RFK Jr. Is Targeting Vaccines And Tylenol. Are Prozac And Ozempic Next? appeared on BitcoinEthereumNews.com. Secretary of Health and Human Services Robert F. Kennedy Jr. The Associated Press Tylenol maker Kenvue is reeling after unsupported claims that its popular drug causes autism. Kennedy is unlikely to stop there. Tylenol may be only the beginning. For years, Robert F. Kennedy Jr. has railed against a number of medications and therapeutics claiming without scientific consensus or evidence that they cause some kind of harm — autism (Tylenol), suicidal thoughts (Ozempic). Now, as President Trump’s head of Health and Human Services, he’s begun turning his opinions into public policy. His Make American Healthy Again initiative has already made it harder for people to get vaccinated against COVID-19 and pushed unverified claims about Tylenol, and he’s just getting started. So what might be next? Kennedy’s already told us. On Monday, Kennedy and FDA Commissioner Marty Makary wrote in a letter to 22 Republican attorneys general that the FDA was reviewing evidence about the safety of abortion drug, mifepristone, which is used in nearly two-thirds of medical abortions. If access to the pill were restricted, it would significantly cut back on abortion access. Another big target: antidepressants. During Kennedy’s confirmation hearings, he falsely claimed that people have a harder time stopping the use of serotonin-based antidepressants “than people have getting off of heroin.” He’s also made the unfounded claim that teenagers who use them are more likely to commit school shootings (they aren’t.) One of the goals of Kennedy’s “Make America Healthy Again” movement is to “assess the prevalence of and threat posed by the prescription of selective serotonin reuptake inhibitors.” Any restrictions on them would be a grave concern to the approximately 11% of the population that uses them to treat depression, anxiety and other issues. Another frequent target of Kennedy’s are statins, which more than 92 million Americans…
Share
BitcoinEthereumNews2025/09/26 19:16
Share